Conference presentations

Export 18 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2017
Volz E, Le Vu S, Ratmann O, Tostevin A, Delpech V, Brown A, Gill NO, Fraser C.  2017.  Phylodynamic analysis to guide allocation of Pre-Exposure Prophylaxis in the United Kingdom. 24th International HIV Dynamics and Evolution.
2016
Hue S, Villanueva RMucio, Tostevin A, Delpech V, Pozniak A, Ashton L, Pillay D, Goldstein R, UK HIV Drug Resistance Database.  2016.  Probabalistic Estimation of HIV-1 Subtype B Transmission Rates from Viral Phylogenies. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
2014
K Bouzidi E, White E, Mbisa JL, Phillips AN, Mackie N, Pozniak A, Dunn DT.  2014.  Protease mutations emergining on darunavir in protease inhibitor-naive and experienced patients in the UK. International Congress of Drug Therapy in HIV Infection, November 2014.
2012
Castro H, Dunn DT, Cane P A, Asboe D, Cambiano V, Phillips AN, Pillay D, UK HIV Drug Resistance Database.  2012.  Persistence of transmitted HIV drug resistance mutations. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A167.
Sethi G, Sabin CA, Lycett S, Ragonnet-Cronin M, Edwards SG, Fearnhill E, Dunn DT, Delpech V, Phillips AN, Pillay D et al..  2012.  Phylogenetic analysis of HIV transmission among different ethnic MSM groups in the UK. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
Hodcroft E, Fearnhill E, Phillips AN, Dunn DT, Pillay D, Hadfield J, Leigh Brown A, UK HIV Drug Resistance Database.  2012.  Population based study indicates viral genetic effect on HIV virulence is small but significant. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
2011
Hue S, Fearnhill E, Dunn DT, Delpech V, Pillay D, Leigh Brown A, UK HIV Drug Resistance Database.  2011.  Phylogeographic and Risk Group Characteristics of HIV Subtype A Transmission in the UK. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Hue S, Fearnhill E, Dunn DT, Delpech V, Pillay D, Leigh Brown A, UK HIV Drug Resistance Database.  2011.  Phylogeographic and risk group characteristics of HIV-1 Subtype A transmission in the UK. 18th International HIV Dynamics and Evolution Conference, 1-4 May 2011.
Mackie N, Garvey L, Geretti AM, Harrison LJ, Tilston P, Phillips AN, Sabin CA, Dunn DT.  2011.  Predicting NNRTI resistance - do polymorphisms matter? 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Barber TJ, Harrison LJ, Asboe D, Williams I, Bansi L, Pillay D, Dunn DT.  2011.  Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI. 17th Annual Conference of the British HIV Association, 6-8 April 2011.
2010
Boyd K, Walker S, Dunn DT, Judd A, Pillay D, Menson E, Tudor-Williams G, Gibb DM.  2010.  The Prevalence of Darunavir Associated Mutations in PI-naive and PI-experienced HIV-1 Infected Children in the UK. 17th Conference on Retroviruses and Opportunistic Infections, February 2010.
2009
Hughes GJ, Leigh Brown A, Bollback J, Rambaut A, Fearnhill E, Dunn DT, UK Collaborative Group on HIV Drug Resistance.  2009.  Phylodynamic analysis of non-B HIV in the United Kingdom reveals substantial post-immigration transmission but longer intervals between transmissions than for subtype B. 16th Conference on Retroviruses and Opportunistic Infections, February 2009.
Price H., Dunn DT, Asboe D, Pozniak A, Gazzard B, Pillay D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2009.  Positive and negative drug selection pressures on the N348I connection domain mutation; new insights from in vivo data. 18th International HIV Drug Resistance Workshop, June 2009.
2008
Gifford RJM, de Oliveira T, Rambaut A, Pybus OG, Dunn DT, Vandamme A.M, Kellam P, Pillay D, UK HIV Drug Resistance Database.  2008.  Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. 15th Conference on Retroviruses and Opportunistic Infections, February 2008.
Geretti AM, Phillips AN, Kaye S, Booth C, Garcia A, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels. 17th International HIV Drug Resistance Workshop, 10-14 June 2008.
2005
Dunn DT, UK HIV Drug Resistance Database.  2005.  Patterns of thymidine analogue mutations (TAMS) in samples sent for routine HIV drug resistance testing. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Grover D, Allen L, Edwards SG, Green H, Copas A, Forsyth S, Pillay D, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Predictors of death and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
2004
Dunn DT, Green H, Matthias R, Woodburn P, Gifford RJM, Chrystie I, Zuckerman M., Geretti AM, Loveday C, Clark J et al..  2004.  Prevalence of reduced drug susceptibility in treatment-naive patients in the UK. 13th International Drug Resistance Workshop, 8-12 June 2004.